IMA Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
IMA Advisory Services's NVO Position: Q2 2026 in Review
IMA Advisory Services increased its Novo Nordisk (NVO) stake by 52% in Q2 2026, buying an estimated $1.93K and bringing the position to 131 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #850.
IMA Advisory Services first reported a position in NVO in Q2 2018 and has held it in 10 quarters since. The position peaked at $8K in Q2 2018. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- IMA Advisory Services held 131 shares of Novo Nordisk worth $6.28K as of Q2 2026.
- IMA Advisory Services bought 45 Novo Nordisk shares in Q2 2026, an estimated $1.93K.
- Novo Nordisk made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #850 holding.
- IMA Advisory Services first reported a position in Novo Nordisk in Q2 2018 and has held it in 10 quarters since.
- IMA Advisory Services's Novo Nordisk position peaked at $8K in Q2 2018.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.